Dinutuximab
Products Dinutuximab was approved in the United States and the EU in 2015 as a concentrate for the preparation of an infusion solution (Unituxin). It has not yet been registered in many countries. Structure and properties Dinutuximab is a chimeric monoclonal antibody (human/mouse). Effects Dinutuximab (ATC L01XC16) has cytotoxic properties. It binds to ganglioside GD2, … Dinutuximab